settlement Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M BD filed the suit against NeuMoDx, now part of Qiagen, in 2019 for infringing patents related to the use of microfluidic cartridges for molecular diagnostics. Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029. Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Cancer Genetics announced its planned merger with NovellusDx in September 2018, but scuttled the deal with the Israeli company a few months later. 10x Genomics to Pay $25M, Cross-License Patents to End BD Infringement Suit 10x will pay Becton Dickinson $25 million over four years and the firms have agreed to refrain from engaging in a legal battle on other fronts. PacBio, Oxford Nanopore Settle Patent Dispute in Europe Under the terms of the agreement, Oxford Nanopore Technologies will not sell its 2D sequencing products in the UK and in Germany for five years. Apr 20, 2018 Biotheranostics Settles False Claims Allegations With DOJ for $2M Sep 28, 2017 Alere Settles With SEC for $13M Nov 29, 2016 Med BioGene, Helomics Revise Licensing Agreement Jul 22, 2015 Enzo, Siemens Resolve IP Infringement Case Feb 9, 2015 Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains Sep 17, 2014 CareDx Settles with Roche Over Allegations of Breach of Agreement Nov 15, 2012 Alnylam, Tekmira End Litigation with $65M Settlement Premium May 9, 2012 Genetic Technologies, GeneSeek Settle Patent Dispute May 2, 2012 Pacific Biosciences Settles IP Litigation with Life Technologies, Helicos Apr 30, 2012 Vermillion, Bio-Rad Settle Claims Stemming from Sale of Proteomics Technology Mar 7, 2012 Affymetrix Completes Repurchase of $92M of Senior Notes as Part of Settlement Feb 14, 2012 Vermillion Receives $1M in Settlement; Moves to Nasdaq Capital Market Feb 6, 2012 Genetic Technologies, Eurofins STA Labs Settle Infringement Dispute Dec 1, 2011 GTG Settles Dispute, Licenses Technology to AutoImmun Nov 28, 2011 Rosetta Defaults on Payment to Prometheus, Warns of Potential Bankruptcy Protection Oct 27, 2011 Caliper Settles Shareholder Lawsuits Tied to Acquisition by PerkinElmer Jul 21, 2011 GE Healthcare, Beckman Coulter Settle Nucleic Acid Sample Prep Lawsuit Premium May 17, 2011 U of Washington, Pharmigene Resolve IP Dispute, Reach Licensing Deal Dec 2, 2010 Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab Premium Nov 23, 2010 Rosetta, Prometheus Settle Arbitration on MicroRNA Tests Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible, former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more. Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.